Selected research
Market Structure
Global Preformulation CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Preformulation CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Preformulation CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Preformulation CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Preformulation CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Preformulation CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Preformulation CDMO Service include Aenova, Ascendia Pharmaceutical, Aurigene Pharmaceutical Services, Corealis Pharma, CritiTech, Crystal Pharmatech, DPT Laboratories, Eirgen Pharma and Eurofins Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Preformulation CDMO Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Preformulation CDMO Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Preformulation CDMO Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Preformulation CDMO Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Preformulation CDMO Service Segment by Company
Aenova
Ascendia Pharmaceutical
Aurigene Pharmaceutical Services
Corealis Pharma
CritiTech
Crystal Pharmatech
DPT Laboratories
Eirgen Pharma
Eurofins Scientific
Koziatek Consulting
Lonza
Oakwood Labs
Quotient Sciences
Sofpromed
Upperton Pharma Solutions
American Pharmaceutical Review
Bluepharma
Preformulation CDMO Service Segment by Type
Basic Characteristics CDMO Service
Pre-formulation Research CDMO Service
Prototype Formulation Development CDMO Service
Preformulation CDMO Service Segment by Application
Innovative Drug Development
Improved New Drug Development
Generic and Biosimilar Drug Development
Others
Preformulation CDMO Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preformulation CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Preformulation CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preformulation CDMO Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Preformulation CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preformulation CDMO Service industry.
Chapter 3: Detailed analysis of Preformulation CDMO Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Preformulation CDMO Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Basic Characteristics CDMO Service
- Pre-formulation Research CDMO Service
- Prototype Formulation Development CDMO Service
Applications
- Innovative Drug Development
- Improved New Drug Development
- Generic and Biosimilar Drug Development
- Others
Companies covered
- Aenova
- Ascendia Pharmaceutical
- Aurigene Pharmaceutical Services
- Corealis Pharma
- CritiTech
- Crystal Pharmatech
- DPT Laboratories
- Eirgen Pharma
- Eurofins Scientific
- Koziatek Consulting
- Lonza
- Oakwood Labs
- Quotient Sciences
- Sofpromed
- Upperton Pharma Solutions
- American Pharmaceutical Review
- Bluepharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Preformulation CDMO Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Basic Characteristics CDMO Service
- 1.2.3 Pre-formulation Research CDMO Service
- 1.2.4 Prototype Formulation Development CDMO Service
- 1.3 Market Analysis by Application
- 1.3.1 Global Preformulation CDMO Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Innovative Drug Development
- 1.3.3 Improved New Drug Development
- 1.3.4 Generic and Biosimilar Drug Development
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Preformulation CDMO Service Growth Trends by Region
- 1.5.1 Global Preformulation CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Preformulation CDMO Service Market Size by Region (2021-2026)
- 1.5.3 Preformulation CDMO Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Preformulation CDMO Service Market Dynamics
- 2.1 Preformulation CDMO Service Industry Trends
- 2.2 Preformulation CDMO Service Industry Drivers
- 2.3 Preformulation CDMO Service Industry Opportunities and Challenges
- 2.4 Preformulation CDMO Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Preformulation CDMO Service Revenue by Company (2021-2026)
- 3.2 Global Preformulation CDMO Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Preformulation CDMO Service Key Company Head office and Area Served
- 3.4 Global Preformulation CDMO Service Company, Product Type & Application
- 3.5 Global Preformulation CDMO Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Preformulation CDMO Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Preformulation CDMO Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Preformulation CDMO Service Tier 1, Tier 2, and Tier 3
4 Preformulation CDMO Service Market by Type
- 4.1 Global Preformulation CDMO Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Preformulation CDMO Service Market Size by Type (2021-2032)
- 4.3 Global Preformulation CDMO Service Market Size Share by Type (2021-2032)
5 Preformulation CDMO Service Market by Application
- 5.1 Global Preformulation CDMO Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Preformulation CDMO Service Market Size by Application (2021-2032)
- 5.3 Global Preformulation CDMO Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Aenova
- 6.1.1 Aenova Company Information
- 6.1.2 Aenova Business Overview
- 6.1.3 Aenova Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Aenova Preformulation CDMO Service Product Portfolio
- 6.1.5 Aenova Recent Developments
- 6.2 Ascendia Pharmaceutical
- 6.2.1 Ascendia Pharmaceutical Company Information
- 6.2.2 Ascendia Pharmaceutical Business Overview
- 6.2.3 Ascendia Pharmaceutical Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Ascendia Pharmaceutical Preformulation CDMO Service Product Portfolio
- 6.2.5 Ascendia Pharmaceutical Recent Developments
- 6.3 Aurigene Pharmaceutical Services
- 6.3.1 Aurigene Pharmaceutical Services Company Information
- 6.3.2 Aurigene Pharmaceutical Services Business Overview
- 6.3.3 Aurigene Pharmaceutical Services Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Aurigene Pharmaceutical Services Preformulation CDMO Service Product Portfolio
- 6.3.5 Aurigene Pharmaceutical Services Recent Developments
- 6.4 Corealis Pharma
- 6.4.1 Corealis Pharma Company Information
- 6.4.2 Corealis Pharma Business Overview
- 6.4.3 Corealis Pharma Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Corealis Pharma Preformulation CDMO Service Product Portfolio
- 6.4.5 Corealis Pharma Recent Developments
- 6.5 CritiTech
- 6.5.1 CritiTech Company Information
- 6.5.2 CritiTech Business Overview
- 6.5.3 CritiTech Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 CritiTech Preformulation CDMO Service Product Portfolio
- 6.5.5 CritiTech Recent Developments
- 6.6 Crystal Pharmatech
- 6.6.1 Crystal Pharmatech Company Information
- 6.6.2 Crystal Pharmatech Business Overview
- 6.6.3 Crystal Pharmatech Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Crystal Pharmatech Preformulation CDMO Service Product Portfolio
- 6.6.5 Crystal Pharmatech Recent Developments
- 6.7 DPT Laboratories
- 6.7.1 DPT Laboratories Company Information
- 6.7.2 DPT Laboratories Business Overview
- 6.7.3 DPT Laboratories Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 DPT Laboratories Preformulation CDMO Service Product Portfolio
- 6.7.5 DPT Laboratories Recent Developments
- 6.8 Eirgen Pharma
- 6.8.1 Eirgen Pharma Company Information
- 6.8.2 Eirgen Pharma Business Overview
- 6.8.3 Eirgen Pharma Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Eirgen Pharma Preformulation CDMO Service Product Portfolio
- 6.8.5 Eirgen Pharma Recent Developments
- 6.9 Eurofins Scientific
- 6.9.1 Eurofins Scientific Company Information
- 6.9.2 Eurofins Scientific Business Overview
- 6.9.3 Eurofins Scientific Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Eurofins Scientific Preformulation CDMO Service Product Portfolio
- 6.9.5 Eurofins Scientific Recent Developments
- 6.10 Koziatek Consulting
- 6.10.1 Koziatek Consulting Company Information
- 6.10.2 Koziatek Consulting Business Overview
- 6.10.3 Koziatek Consulting Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Koziatek Consulting Preformulation CDMO Service Product Portfolio
- 6.10.5 Koziatek Consulting Recent Developments
- 6.11 Lonza
- 6.11.1 Lonza Company Information
- 6.11.2 Lonza Business Overview
- 6.11.3 Lonza Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Lonza Preformulation CDMO Service Product Portfolio
- 6.11.5 Lonza Recent Developments
- 6.12 Oakwood Labs
- 6.12.1 Oakwood Labs Company Information
- 6.12.2 Oakwood Labs Business Overview
- 6.12.3 Oakwood Labs Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Oakwood Labs Preformulation CDMO Service Product Portfolio
- 6.12.5 Oakwood Labs Recent Developments
- 6.13 Quotient Sciences
- 6.13.1 Quotient Sciences Company Information
- 6.13.2 Quotient Sciences Business Overview
- 6.13.3 Quotient Sciences Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Quotient Sciences Preformulation CDMO Service Product Portfolio
- 6.13.5 Quotient Sciences Recent Developments
- 6.14 Sofpromed
- 6.14.1 Sofpromed Company Information
- 6.14.2 Sofpromed Business Overview
- 6.14.3 Sofpromed Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 Sofpromed Preformulation CDMO Service Product Portfolio
- 6.14.5 Sofpromed Recent Developments
- 6.15 Upperton Pharma Solutions
- 6.15.1 Upperton Pharma Solutions Company Information
- 6.15.2 Upperton Pharma Solutions Business Overview
- 6.15.3 Upperton Pharma Solutions Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Upperton Pharma Solutions Preformulation CDMO Service Product Portfolio
- 6.15.5 Upperton Pharma Solutions Recent Developments
- 6.16 American Pharmaceutical Review
- 6.16.1 American Pharmaceutical Review Company Information
- 6.16.2 American Pharmaceutical Review Business Overview
- 6.16.3 American Pharmaceutical Review Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 American Pharmaceutical Review Preformulation CDMO Service Product Portfolio
- 6.16.5 American Pharmaceutical Review Recent Developments
- 6.17 Bluepharma
- 6.17.1 Bluepharma Company Information
- 6.17.2 Bluepharma Business Overview
- 6.17.3 Bluepharma Preformulation CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Bluepharma Preformulation CDMO Service Product Portfolio
- 6.17.5 Bluepharma Recent Developments
7 North America
- 7.1 North America Preformulation CDMO Service Market Size (2021-2032)
- 7.2 North America Preformulation CDMO Service Market Size by Type
- 7.2.1 North America Preformulation CDMO Service Market Size by Type (2021-2026)
- 7.2.2 North America Preformulation CDMO Service Market Size by Type (2027-2032)
- 7.2.3 North America Preformulation CDMO Service Market Share by Type (2021-2032)
- 7.3 North America Preformulation CDMO Service Market Size by Application
- 7.3.1 North America Preformulation CDMO Service Market Size by Application (2021-2026)
- 7.3.2 North America Preformulation CDMO Service Market Size by Application (2027-2032)
- 7.3.3 North America Preformulation CDMO Service Market Share by Application (2021-2032)
- 7.4 North America Preformulation CDMO Service Market Size by Country
- 7.4.1 North America Preformulation CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Preformulation CDMO Service Market Size by Country (2021-2026)
- 7.4.3 North America Preformulation CDMO Service Market Size by Country (2027-2032)
- 7.4.4 North America Preformulation CDMO Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Preformulation CDMO Service Market Size (2021-2032)
- 8.2 Europe Preformulation CDMO Service Market Size by Type
- 8.2.1 Europe Preformulation CDMO Service Market Size by Type (2021-2026)
- 8.2.2 Europe Preformulation CDMO Service Market Size by Type (2027-2032)
- 8.2.3 Europe Preformulation CDMO Service Market Share by Type (2021-2032)
- 8.3 Europe Preformulation CDMO Service Market Size by Application
- 8.3.1 Europe Preformulation CDMO Service Market Size by Application (2021-2026)
- 8.3.2 Europe Preformulation CDMO Service Market Size by Application (2027-2032)
- 8.3.3 Europe Preformulation CDMO Service Market Share by Application (2021-2032)
- 8.4 Europe Preformulation CDMO Service Market Size by Country
- 8.4.1 Europe Preformulation CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Preformulation CDMO Service Market Size by Country (2021-2026)
- 8.4.3 Europe Preformulation CDMO Service Market Size by Country (2027-2032)
- 8.4.4 Europe Preformulation CDMO Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Preformulation CDMO Service Market Size (2021-2032)
- 9.2 China Preformulation CDMO Service Market Size by Type
- 9.2.1 China Preformulation CDMO Service Market Size by Type (2021-2026)
- 9.2.2 China Preformulation CDMO Service Market Size by Type (2027-2032)
- 9.2.3 China Preformulation CDMO Service Market Share by Type (2021-2032)
- 9.3 China Preformulation CDMO Service Market Size by Application
- 9.3.1 China Preformulation CDMO Service Market Size by Application (2021-2026)
- 9.3.2 China Preformulation CDMO Service Market Size by Application (2027-2032)
- 9.3.3 China Preformulation CDMO Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Preformulation CDMO Service Market Size (2021-2032)
- 10.2 Asia Preformulation CDMO Service Market Size by Type
- 10.2.1 Asia Preformulation CDMO Service Market Size by Type (2021-2026)
- 10.2.2 Asia Preformulation CDMO Service Market Size by Type (2027-2032)
- 10.2.3 Asia Preformulation CDMO Service Market Share by Type (2021-2032)
- 10.3 Asia Preformulation CDMO Service Market Size by Application
- 10.3.1 Asia Preformulation CDMO Service Market Size by Application (2021-2026)
- 10.3.2 Asia Preformulation CDMO Service Market Size by Application (2027-2032)
- 10.3.3 Asia Preformulation CDMO Service Market Share by Application (2021-2032)
- 10.4 Asia Preformulation CDMO Service Market Size by Country
- 10.4.1 Asia Preformulation CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Preformulation CDMO Service Market Size by Country (2021-2026)
- 10.4.3 Asia Preformulation CDMO Service Market Size by Country (2027-2032)
- 10.4.4 Asia Preformulation CDMO Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Preformulation CDMO Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Preformulation CDMO Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Preformulation CDMO Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Preformulation CDMO Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Preformulation CDMO Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Preformulation CDMO Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Preformulation CDMO Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Preformulation CDMO Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Preformulation CDMO Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Preformulation CDMO Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Preformulation CDMO Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Preformulation CDMO Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Preformulation CDMO Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Preformulation CDMO Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst